Julie Mead
Directeur/Membre du Conseil chez Lucigen Corp.
Profil
Julie Mead is currently the Director at Lucigen Corp.
She completed her undergraduate degree at Illinois State University, her graduate degree at the University of Illinois, and her doctorate at the University of Wisconsin.
Postes actifs de Julie Mead
| Sociétés | Poste | Début |
|---|---|---|
Lucigen Corp.
 Lucigen Corp. Pharmaceuticals: MajorHealth Technology Lucigen Corp. engages in the development, manufacture, and sale of biomedical research products and services. The firm offers products for array-based analysis; cloning kits and vectors; competent cells; enzymes; in vitro transcription; next gen sequencing (NGS); nucleic acid extraction and purification; PCR and amplification; protein expression; and transposon mutagenesis. It also provides NGS and custom competent cell services. The company was founded by David Mead and Thomas W. Schoenfeld in 1998 and is headquartered in Middleton, WI. | Directeur/Membre du Conseil | 01/01/1998 |
Formation de Julie Mead
| Illinois State University | Undergraduate Degree |
| University of Illinois | Graduate Degree |
| University of Wisconsin | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Lucigen Corp.
Lucigen Corp. Pharmaceuticals: MajorHealth Technology Lucigen Corp. engages in the development, manufacture, and sale of biomedical research products and services. The firm offers products for array-based analysis; cloning kits and vectors; competent cells; enzymes; in vitro transcription; next gen sequencing (NGS); nucleic acid extraction and purification; PCR and amplification; protein expression; and transposon mutagenesis. It also provides NGS and custom competent cell services. The company was founded by David Mead and Thomas W. Schoenfeld in 1998 and is headquartered in Middleton, WI. | Health Technology |
